Le Lézard
Classified in: Science and technology, Business
Subject: OFR

Buy-backs of shares in CoinShares International Limited


SAINT HELIER, Jersey, Jan. 26, 2023 /PRNewswire/ -- As announced on 30 December 2022, the Board of Directors of CoinShares International Limited ("CoinShares" or the "Company") (Nasdaq Stockholm Market: CS; US OTCQX: CNSRF), Europe's largest and leading digital asset investment and trading group, resolved to implement a share buy-back program and repurchase shares on Nasdaq Stockholm Market during the period 3 January 2023, up to and including 3 April 2023 for total maximum amount of SEK 25 million in accordance with the authorisation from the Annual General Meeting on 20 June 2022.

 

Appendix to share buy-back release 1.26.23

 

The Board of Directors' resolution to implement the share buy-back program was made after the Board's review of the Company's capital structure and was implemented for the purposes of reducing the capital of the Company.

The share buy-back program is carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 ("MAR") and the Commission Delegated Regulation (EU) No 2016/1052 (the "Safe Harbour Regulation").

The Company today announces that share buy-backs of shares in the Company (ISIN: JE00BLD8Y945) have been effected as set forth below (aggregated level):

Date

Number of
shares
acquired

Lowest price
paid (SEK)

Highest price
paid (SEK)

Volume
weighted
average (SEK)

19 January 2023

2,650

25.50

26.35

26.12

20 January 2023

1,950

26.65

26.90

26.83


4,600




All share buy-backs have been carried out on Nasdaq Stockholm Market by the Company. Following the above repurchases, the Company's holding of own shares as of 26 January 2023 amounts to 222,095 shares. The total number of shares in CoinShares amounts to 68,135,425.

For a full break-down of repurchases made, please refer to the attached announcement.

About CoinShares

CoinShares is Europe's largest and leading digital asset investment and trading group, managing billions of assets on behalf of a global client base. Our mission is to expand investing into digital assets with our trusted, regulated, best-in-class product suite that provides investors with trust and transparency when accessing cryptocurrencies. We believe that Bitcoin and blockchain networks are landmark innovations that will fundamentally reshape the global financial system and the way we interact digitally, and investors should be able to participate in this transformation. CoinShares is publicly listed on the Nasdaq Stockholm under ticker CS and the OTCQX under the ticker CNSRF. CoinShares has multiple touchpoints with financial regulatory bodies around the world, including the AMF, JFSC and FINRA.

For more information on CoinShares, please visit: https://coinshares.com
Company | +44 (0)1534 513 100 | [email protected]
Investor Relations | +44 (0)1534 513 100 | [email protected]

This information is information that CoinShares International Limited is obliged to make public pursuant to the EU Market Abuse Regulation (596/2014). The information in this press release has been published through the agency of the contact persons set out above, at 08:00 GMT on Thursday, 26 January 2023.

 

CoinShares Logo (PRNewsfoto/CoinShares Group)

 

PDF - https://mma.prnewswire.com/media/1990403/20230126___Appendix_to_press_release___share_buy_back.pdf

Logo - https://mma.prnewswire.com/media/1502126/CoinShares_updated_Logo.jpg


These press releases may also interest you

at 10:45
eBlu Solutions, a leading provider of innovative technology solutions for the specialty healthcare industry, is pleased to announce the addition of Doug Lawrence to the Executive Leadership team in the role of Chief Revenue Officer. "We're not just...

at 10:31
On May 9, The 8th Global ICT Energy Efficiency Summit, themed "Green Site, Building a Brighter Future", was held in Bangkok, Thailand. At this summit, Site Power Facility Domain of Huawei Digital Power launched the All-Scenario Smart Telecom Power...

at 09:05
Cardurion Pharmaceuticals, Inc. ("Cardurion"), a clinical-stage biotechnology company developing next-generation therapeutics for the treatment of cardiovascular diseases, today announced the presentation of positive clinical data from CARDINAL?HF,...

at 09:00
From May 7th to May 9th, 2024, TCT ASIA 2024 was held at the National Exhibition and Convention Center in Shanghai. As a global summit for 3D printing technology, this exhibition brought together numerous industry elites and research experts to...

at 08:00
The ninth annual United Nations Science, Technology, and Innovation Forum (UN STI Forum), dedicated to advancing the Sustainable Development Goals, convened at the UN headquarters in New York on May 9-10, 2024. Under the theme "Science, Technology,...

at 06:00
Replicate Bioscience, a clinical-stage company pioneering novel self-replicating RNA (srRNA) technology for use across a range of infectious disease, oncology,...



News published on and distributed by: